Ferreira, L.O.; Oldemburg, R.A.L.; Leitão Filho, J.M.; Cerveira, R.A.; Vasconcelos, V.W.; da Costa, G.E.; Rodrigues, R.d.R.; Lopes, D.C.F.
Andexanet Alfa versus Four-Factor Prothrombin Complex Concentrate for the Reversal of Factor Xa (FXa) Inhibitor-Associated Intracranial Hemorrhage: A Systematic Review of Retrospective Studies. J. Clin. Med. 2024, 13, 3077.
https://doi.org/10.3390/jcm13113077
AMA Style
Ferreira LO, Oldemburg RAL, Leitão Filho JM, Cerveira RA, Vasconcelos VW, da Costa GE, Rodrigues RdR, Lopes DCF.
Andexanet Alfa versus Four-Factor Prothrombin Complex Concentrate for the Reversal of Factor Xa (FXa) Inhibitor-Associated Intracranial Hemorrhage: A Systematic Review of Retrospective Studies. Journal of Clinical Medicine. 2024; 13(11):3077.
https://doi.org/10.3390/jcm13113077
Chicago/Turabian Style
Ferreira, Luan Oliveira, Ricardo Andres León Oldemburg, João Monteiro Leitão Filho, Rodrigo Arcoverde Cerveira, Victoria Winkler Vasconcelos, Giovana Escribano da Costa, Roseny dos Reis Rodrigues, and Dielly Catrina Favacho Lopes.
2024. "Andexanet Alfa versus Four-Factor Prothrombin Complex Concentrate for the Reversal of Factor Xa (FXa) Inhibitor-Associated Intracranial Hemorrhage: A Systematic Review of Retrospective Studies" Journal of Clinical Medicine 13, no. 11: 3077.
https://doi.org/10.3390/jcm13113077
APA Style
Ferreira, L. O., Oldemburg, R. A. L., Leitão Filho, J. M., Cerveira, R. A., Vasconcelos, V. W., da Costa, G. E., Rodrigues, R. d. R., & Lopes, D. C. F.
(2024). Andexanet Alfa versus Four-Factor Prothrombin Complex Concentrate for the Reversal of Factor Xa (FXa) Inhibitor-Associated Intracranial Hemorrhage: A Systematic Review of Retrospective Studies. Journal of Clinical Medicine, 13(11), 3077.
https://doi.org/10.3390/jcm13113077
